These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18805829)

  • 1. Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy.
    Araújo-Vilar D; Lattanzi G; González-Méndez B; Costa-Freitas AT; Prieto D; Columbaro M; Mattioli E; Victoria B; Martínez-Sánchez N; Ramazanova A; Fraga M; Beiras A; Forteza J; Domínguez-Gerpe L; Calvo C; Lado-Abeal J
    J Med Genet; 2009 Jan; 46(1):40-8. PubMed ID: 18805829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
    Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations.
    Araújo-Vilar D; Victoria B; González-Méndez B; Barreiro F; Fernández-Rodríguez B; Cereijo R; Gallego-Escuredo JM; Villarroya F; Pañeda-Menéndez A
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):816-24. PubMed ID: 21883346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
    Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C
    Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
    Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional decrease of subcutaneous adipose tissue in patients with type 2 familial partial lipodystrophy is associated with changes in thyroid hormone metabolism.
    Lado-Abeal J; Calvo RM; Victoria B; Castro I; Obregon MJ; Araujo-Vilar D
    Thyroid; 2010 Apr; 20(4):419-24. PubMed ID: 20373986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
    Friesen M; Cowan CA
    Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinol acid receptor B gene is hypermethylated in patients with familial partial lipodystrophy.
    Cortese R; Eckhardt F; Volleth M; Wehnert M; Koelsch U; Wieacker P; Brune T
    J Mol Endocrinol; 2007 Jun; 38(6):663-71. PubMed ID: 17556535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction.
    Schena E; Mattioli E; Peres C; Zanotti L; Morselli P; Iozzo P; Guzzardi MA; Bernardini C; Forni M; Nesci S; Caprio M; Cecchetti C; Pagotto U; Gabusi E; Cattini L; Lisignoli G; Blalock W; Gambineri A; Lattanzi G
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
    Lanktree M; Cao H; Rabkin SW; Hanna A; Hegele RA
    Clin Genet; 2007 Feb; 71(2):183-6. PubMed ID: 17250669
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear envelope-related lipodystrophies.
    Guénantin AC; Briand N; Bidault G; Afonso P; Béréziat V; Vatier C; Lascols O; Caron-Debarle M; Capeau J; Vigouroux C
    Semin Cell Dev Biol; 2014 May; 29():148-57. PubMed ID: 24384368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
    Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
    J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
    Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
    Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
    Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
    AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
    Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
    Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2.
    Corsa CAS; Walsh CM; Bagchi DP; Foss Freitas MC; Li Z; Hardij J; Granger K; Mori H; Schill RL; Lewis KT; Maung JN; Azaria RD; Rothberg AE; Oral EA; MacDougald OA
    Diabetes; 2021 Sep; 70(9):1970-1984. PubMed ID: 34088712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.
    Luedtke A; Boschmann M; Colpe C; Engeli S; Adams F; Birkenfeld AL; Haufe S; Rahn G; Luft FC; Schmidt HH; Jordan J
    Horm Metab Res; 2012 Apr; 44(4):306-11. PubMed ID: 22274718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix remodeling and transforming growth factor-β signaling abnormalities induced by lamin A/C variants that cause lipodystrophy.
    Le Dour C; Wu W; Béréziat V; Capeau J; Vigouroux C; Worman HJ
    J Lipid Res; 2017 Jan; 58(1):151-163. PubMed ID: 27845687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of β-Estradiol on Adipogenesis in a 3T3-L1 Cell Model of Prelamin A Accumulation.
    Cobelo-Gómez S; Sánchez-Iglesias S; Fernández-Pombo A; Araújo-Vilar D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
    Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
    Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.